ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Tuesday, November 10, 2015

9:00AM-11:00AM
Abstract Number: 2282
“Doing Every-Day Life” with Primary Sjögren’s Syndrome: Factors Predicting Difficulties Performing Daily Activities and Taking on Life Roles
Epidemiology and Public Health Poster (ARHP)
9:00AM-11:00AM
Abstract Number: 2338
“It Was like No One Is Listening to Me”�: A Qualitative Study of the Lived Experiences of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance in Assessments of Disease Activity
Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences
9:00AM-11:00AM
Abstract Number: 2217
#Rheumjc: Development, Implementation and Analysis of an International Twitter-Based Rheumatology Journal Club
Education Poster II
9:00AM-11:00AM
Abstract Number: 2555
14-3-3η As a Novel RA Drug Target: Anti-14-3-3η Monoclonal Antibody Delays the Onset and Mitigates the Severity of Arthritis in CIA Mice
Rheumatoid Arthritis - Animal Models Poster
9:00AM-11:00AM
Abstract Number: 2605
14-3-3η Positive Status and Higher Titres Are Associated with More Severe RA
Rheumatoid Arthritis - Clinical Aspects Poster Session III
9:00AM-11:00AM
Abstract Number: 2957
25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus: Results from a Controlled Study
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III
9:00AM-11:00AM
Abstract Number: 2706
3D Location of Erosions in an Early Rheumatoid Arthritis Population: An MRI Study Using Statistical Shape Models with Implications for Pathogenesis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III
9:00AM-11:00AM
Abstract Number: 2344
A 3-Year Follow-up Study of Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant, or Unresponsive to Nonsteroidal Anti-Inflammatory Drugs and/or Colchicine
Metabolic and Crystal Arthropathies Poster II
9:00AM-11:00AM
Abstract Number: 2682
A Brief Patient-Reported Measure of Physical Function Is Sensitive to Changes in a Composite Disease Activity Measure in a Diverse Rheumatoid Arthritis Clinic Setting
Rheumatoid Arthritis - Clinical Aspects Poster Session III
9:00AM-11:00AM
Abstract Number: 2289
A Cervical Radiculopathy Can Cause Chest Pain
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II
9:00AM-11:00AM
Abstract Number: 3034
A Comparative Metabolomic Evaluation of Behcet’s Disease with Arthritis and Seronegative Arthritis Using Synovial Fluid
Vasculitis Poster III
9:00AM-11:00AM
Abstract Number: 2738
A Comparison of EQ5D Index from the UK, US, and Japan Preference Weights Model, and Mapping Algorithm from Clinical Outcomes in Patients with Rheumatoid Arthritis: Results from Golimumab Intravenous Study
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III
9:00AM-11:00AM
Abstract Number: 2533
A Comparison of Pregnancy Outcomes before and after Lupus Diagnosis
Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects Poster Session
9:00AM-11:00AM
Abstract Number: 2815
A Comparison of Th17 Gene Expression in Psoriatic Arthritis Synovial Fluid and Peripheral Blood
Spondylarthropathies and Psoriatic Arthritis Pathogenesis, Etiology Poster I
9:00AM-11:00AM
Abstract Number: 2505
A Fellow Led Quality Improvement Project for Improving Contraceptive Compliance in Women Receiving Teratogenic Medications
Quality Measures and Quality of Care Poster Session
  • 1
  • 2
  • 3
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology